Analysts think CARM stock price could increase by 448%
Jun 07, 2025, 11:25 AM
127.96%
What does CARM do
Carisma Therapeutics, a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focuses on developing immunotherapies for solid tumors, including CAR-M therapies CT-0508 and CT-0525. The company went public in February 2014 and employs 107 people.
3 analysts think CARM stock price will increase by 448.39%. The current median analyst target is $1.02 compared to a current stock price of $0.19. The lowest analysts target is $1.01 and the highest analyst target is $1.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.